Prognostic Role of Osteoprotegerin and Risk of Coronary Artery Calcification: A Systematic Review and Meta-Analysis
Biomarkers in Medicine · 2023
DOI: 10.2217/bmm-2022-0621 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Biomarkers in Medicine, 2023. Verfasst von Sara Samadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran. Hauptthemen laut MEDLINE: Calcinosis, Coronary Artery Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Aim
Coronary artery calcification (CAC) is a predictor of atherosclerosis. However, the association of osteoprotegerin (OPG) with CAC is still controversial.
Methods
Prospective cohort studies that provided odds ratios with 95% CIs were included from PubMed, Embase, Web of Science and Scopus through July 2022.
Results
Out of 14 studies included in the systematic review, three studies with 7642 participants were included in the meta-analysis. The pooled odds ratio indicated a significant association between higher OPG levels and accelerated risk of CAC (1.15; 95% CI: 1.03-1.30; p < 0.001) with relatively no heterogeneity between studies (I2 = 0%; p = 0.43).
Conclusion
The results indicated that increased concentrations of OPG are positively associated with a 15% elevated odds of CAC after adjustment of major covariates. This meta-analysis included published data on the relationship between levels of osteoprotegerin, an important molecule in the bone production process, and the risk of accumulation of calcium deposits in the vessels supplying blood to the heart. Since these calcium deposits are an early sign of heart disease and subsequently heart attacks, understanding the mechanisms and finding ways to treat patients earlier can be of great importance. This study found that the higher the osteoprotegerin level a patient has, the higher the patient's chance of having calcium deposits in his or her heart vessels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran.
- Department of Epidemiology, Faculty of Health, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran.
- Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran.
- Department of Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran.
ORCID-Profile: Sara Samadi, Masoumeh Sadeghi, Amir H Mohammadpour, Vahid Jomehzadeh
Zitieren
APA
Samadi, S., Sadeghi, M., Dashtbayaz, R. J., Nezamdoost, S., Mohammadpour, A. H., & Jomehzadeh, V. (2023). Prognostic Role of Osteoprotegerin and Risk of Coronary Artery Calcification: A Systematic Review and Meta-Analysis. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2022-0621
Vancouver
Samadi S, Sadeghi M, Dashtbayaz RJ, Nezamdoost S, Mohammadpour AH, Jomehzadeh V. Prognostic Role of Osteoprotegerin and Risk of Coronary Artery Calcification: A Systematic Review and Meta-Analysis. Biomarkers in Medicine. 2023. doi:10.2217/bmm-2022-0621
BibTeX
@article{Samadi2023,
author = {Samadi, Sara and Sadeghi, Masoumeh and Dashtbayaz, Reza Javidi and Nezamdoost, Shirin and Mohammadpour, Amir H and Jomehzadeh, Vahid},
title = {Prognostic Role of Osteoprotegerin and Risk of Coronary Artery Calcification: A Systematic Review and Meta-Analysis},
journal = {Biomarkers in Medicine},
year = {2023},
doi = {10.2217/bmm-2022-0621}
}
EUVIMED